在对涉及 NSCLC 精准肿瘤学疗法的 3 期随机对照试验进行伦理评估时,Equipoise 仍是一个主要考虑因素

IF 21 1区 医学 Q1 ONCOLOGY
Sarah Heynemann M.B.B.S., BMedSci, FRACP, MBioeth , Wendy Lipworth M.B.B.S., PhD , Sue-Anne McLachlan M.B.B.S., MSc, FRACP , Jennifer Philip M.B.B.S., GDipPallMed, MMed, PhD , Tom John M.B.B.S., PhD, FRACP , Ian Kerridge BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA
{"title":"在对涉及 NSCLC 精准肿瘤学疗法的 3 期随机对照试验进行伦理评估时,Equipoise 仍是一个主要考虑因素","authors":"Sarah Heynemann M.B.B.S., BMedSci, FRACP, MBioeth , Wendy Lipworth M.B.B.S., PhD , Sue-Anne McLachlan M.B.B.S., MSc, FRACP , Jennifer Philip M.B.B.S., GDipPallMed, MMed, PhD , Tom John M.B.B.S., PhD, FRACP , Ian Kerridge BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA","doi":"10.1016/j.jtho.2024.07.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 11","pages":"Pages 1504-1508"},"PeriodicalIF":21.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Equipoise Remains a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC\",\"authors\":\"Sarah Heynemann M.B.B.S., BMedSci, FRACP, MBioeth , Wendy Lipworth M.B.B.S., PhD , Sue-Anne McLachlan M.B.B.S., MSc, FRACP , Jennifer Philip M.B.B.S., GDipPallMed, MMed, PhD , Tom John M.B.B.S., PhD, FRACP , Ian Kerridge BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA\",\"doi\":\"10.1016/j.jtho.2024.07.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"19 11\",\"pages\":\"Pages 1504-1508\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086424006683\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086424006683","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Equipoise Remains a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Thoracic Oncology
Journal of Thoracic Oncology 医学-呼吸系统
CiteScore
36.00
自引率
3.90%
发文量
1406
审稿时长
13 days
期刊介绍: Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信